Skye Bioscience, Inc. (SKYE)
0.7208
-0.06
(-7.27%)
USD |
NASDAQ |
Feb 10, 16:00
0.7208
0.00 (0.00%)
After-Hours: 18:53
Skye Bioscience Market Cap : 23.11M for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Assertio Holdings, Inc. | 74.56M |
| Eli Lilly & Co. | 917.28B |
| Theravance Biopharma, Inc. | 982.03M |
| Viking Therapeutics, Inc. | 3.245B |
| Kyntra Bio, Inc. | 32.48M |
Market Cap Related Metrics
| PEG Ratio | -0.0105 |
| Price to Book Value | 0.7037 |
| Price | 0.7208 |
| Earnings Yield | -178.9% |
| PEGY Ratio | -0.0105 |